FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2075430111> ?p ?o ?g. }

• W2075430111 abstract "The new angiotensin-converting enzyme (ACE) inhibitor fosinopril was compared with the ACE inhibitor enalapril in a multicenter (n = 11), multinational (Denmark, Finland, Iceland, Norway, and Sweden), double-blind, randomized, parallel-group 24-week study in 195 patients with mild to moderate essential hypertension [supine diastolic blood pressure, (SDBP) > or = 95 to < or = 110 mm Hg]. After discontinuing all previous antihypertensive medication, patients were entered into a placebo lead-in period of 4-6 weeks, followed by 24 weeks of randomized treatment with the active compounds administered with a double-dummy technique. The dose of fosinopril was 20 mg, which could be increased to 40 mg after 8 weeks (average 25.6 mg); that of enalapril was 10 mg, which could be increased to 20 mg after 8 weeks (average 12.9 mg). Hydrochlorothiazide 12.5 mg could be added after 16 weeks and was administered to 27% of the patients in the fosinopril group and to 30% in the enalapril group. All drugs were administered once daily. Supine systolic BP (SSBP) decreased from 157 to 143 mm Hg in the fosinopril group (p < 0.01), and from 159 to 147 mm Hg in the enalapril group (p < 0.01). SSDP decreased from 100 to 89 mm Hg in the fosinopril group (p < 0.01) and from 100 to 92 mm Hg in the enalapril group (p < 0.01). Throughout the study period, fosinopril reduced SSBP and SDBP numerically more than did enalapril, by 0-3 mm Hg. Adverse events (AE) caused withdrawal of study medication in 8 patients in the fosinopril group and in 14 patients in the enalapril group (NS). The number of reported AE was not statistically different in the two groups. Inhibition of the ACE was assessed in a subgroup of patients (n = 26, 13 in each group). Fosinopril caused a greater inhibition of ACE at the doses used in the present study, which was statistically significant. Both fosinopril and enalapril caused statistically significant reductions in BP of a similar magnitude, and both agents were well tolerated. However, fosinopril was consistently numerically slightly more effective than enalapril in reducing BP. There were fewer withdrawals due to AE (NS) in the fosinopril group, and the overall recorded AE were fewer in the fosinopril group (NS)." @default.
• W2075430111 created "2016-06-24" @default.
• W2075430111 creator A5005764059 @default.
• W2075430111 creator A5034450801 @default.
• W2075430111 creator A5034516594 @default.
• W2075430111 creator A5040588435 @default.
• W2075430111 creator A5041880236 @default.
• W2075430111 creator A5045054834 @default.
• W2075430111 creator A5056780597 @default.
• W2075430111 creator A5061186360 @default.
• W2075430111 creator A5061941608 @default.
• W2075430111 creator A5062744245 @default.
• W2075430111 creator A5070288655 @default.
• W2075430111 creator A5076621081 @default.
• W2075430111 date "1996-07-01" @default.
• W2075430111 modified "2023-10-16" @default.
• W2075430111 title "Fosinopril Versus Enalapril in the Treatment of Hypertension: A Double-Blind Study in 195 Patients" @default.
• W2075430111 cites W1985228520 @default.
• W2075430111 cites W1986701315 @default.
• W2075430111 cites W2079955719 @default.
• W2075430111 cites W2090891813 @default.
• W2075430111 cites W2157246974 @default.
• W2075430111 cites W2166725046 @default.
• W2075430111 cites W2167596953 @default.
• W2075430111 cites W7099363 @default.
• W2075430111 doi "https://doi.org/10.1097/00005344-199607000-00001" @default.
• W2075430111 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8797128" @default.
• W2075430111 hasPublicationYear "1996" @default.
• W2075430111 type Work @default.
• W2075430111 sameAs 2075430111 @default.
• W2075430111 citedByCount "8" @default.
• W2075430111 countsByYear W20754301112013 @default.
• W2075430111 crossrefType "journal-article" @default.
• W2075430111 hasAuthorship W2075430111A5005764059 @default.
• W2075430111 hasAuthorship W2075430111A5034450801 @default.
• W2075430111 hasAuthorship W2075430111A5034516594 @default.
• W2075430111 hasAuthorship W2075430111A5040588435 @default.
• W2075430111 hasAuthorship W2075430111A5041880236 @default.
• W2075430111 hasAuthorship W2075430111A5045054834 @default.
• W2075430111 hasAuthorship W2075430111A5056780597 @default.
• W2075430111 hasAuthorship W2075430111A5061186360 @default.
• W2075430111 hasAuthorship W2075430111A5061941608 @default.
• W2075430111 hasAuthorship W2075430111A5062744245 @default.
• W2075430111 hasAuthorship W2075430111A5070288655 @default.
• W2075430111 hasAuthorship W2075430111A5076621081 @default.
• W2075430111 hasConcept C125567185 @default.
• W2075430111 hasConcept C126322002 @default.
• W2075430111 hasConcept C126894567 @default.
• W2075430111 hasConcept C134018914 @default.
• W2075430111 hasConcept C142724271 @default.
• W2075430111 hasConcept C204787440 @default.
• W2075430111 hasConcept C27016395 @default.
• W2075430111 hasConcept C27081682 @default.
• W2075430111 hasConcept C2775940317 @default.
• W2075430111 hasConcept C2777097880 @default.
• W2075430111 hasConcept C2779611605 @default.
• W2075430111 hasConcept C2780361556 @default.
• W2075430111 hasConcept C2780436477 @default.
• W2075430111 hasConcept C71924100 @default.
• W2075430111 hasConcept C84393581 @default.
• W2075430111 hasConceptScore W2075430111C125567185 @default.
• W2075430111 hasConceptScore W2075430111C126322002 @default.
• W2075430111 hasConceptScore W2075430111C126894567 @default.
• W2075430111 hasConceptScore W2075430111C134018914 @default.
• W2075430111 hasConceptScore W2075430111C142724271 @default.
• W2075430111 hasConceptScore W2075430111C204787440 @default.
• W2075430111 hasConceptScore W2075430111C27016395 @default.
• W2075430111 hasConceptScore W2075430111C27081682 @default.
• W2075430111 hasConceptScore W2075430111C2775940317 @default.
• W2075430111 hasConceptScore W2075430111C2777097880 @default.
• W2075430111 hasConceptScore W2075430111C2779611605 @default.
• W2075430111 hasConceptScore W2075430111C2780361556 @default.
• W2075430111 hasConceptScore W2075430111C2780436477 @default.
• W2075430111 hasConceptScore W2075430111C71924100 @default.
• W2075430111 hasConceptScore W2075430111C84393581 @default.
• W2075430111 hasLocation W20754301111 @default.
• W2075430111 hasLocation W20754301112 @default.
• W2075430111 hasOpenAccess W2075430111 @default.
• W2075430111 hasPrimaryLocation W20754301111 @default.
• W2075430111 hasRelatedWork W1645405152 @default.
• W2075430111 hasRelatedWork W1843339903 @default.
• W2075430111 hasRelatedWork W2004373479 @default.
• W2075430111 hasRelatedWork W2016337525 @default.
• W2075430111 hasRelatedWork W2069755255 @default.
• W2075430111 hasRelatedWork W2075430111 @default.
• W2075430111 hasRelatedWork W2133107921 @default.
• W2075430111 hasRelatedWork W2409039537 @default.
• W2075430111 hasRelatedWork W2413230715 @default.
• W2075430111 hasRelatedWork W2465866313 @default.
• W2075430111 isParatext "false" @default.
• W2075430111 isRetracted "false" @default.
• W2075430111 magId "2075430111" @default.
• W2075430111 workType "article" @default.